In fact, EphA2 is overexpressed in many solid tumors, like gastric, esophageal, colorectal, cervical, breast, ovary, prostate, pancreas, neck, renal, lung, bladder cancers, melanoma, and glioblastoma [110,111,112,113,114]. Here, EPHA2 is linked to melanoma.